(VIANEWS) – PCM Fund (PCM), Invesco Credit Opportunities Fund (VTA), Cullen/Frost Bankers (CFR) are the highest payout ratio stocks on this list.

Here’s the data we’ve collected of stocks with a high payout ratio up to now. The payout ratio in itself isn’t a guarantee of a future good investment but it’s an indicator of whether dividends are being paid and how the company chooses to issue them.

When investigating a potential investment, the dividend payout ratio is a good statistic to know so here is a list of some companies with an above 30% payout ratio.

1. PCM Fund (PCM)

240% Payout Ratio

PCM Fund Inc. is a closed ended fixed income mutual fund launched and managed by Allianz Global Investors Fund Management LLC.

Volume

Today’s last reported volume for PCM Fund is 19596, 31.32% below its average volume of 28535.

As maintained by Morningstar, Inc., the next dividend payment is on Aug 10, 2021, the estimated forward annual dividend rate is 0.96 and the estimated forward annual dividend yield is 8%.

Year-on-year quarterly revenue growth grew by 6.3%, now sitting on 14.13M for the twelve trailing months.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.19%.

Volatility

PCM Fund’s last day, week, and month’s current volatility was 0.70%, 0.73%, and 0.65%, respectively.

PCM Fund’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 0.70% (day), 1.65% (last week), and 1.65% (last month), respectively.

PCM Fund’s Stock Yearly Top and Bottom Value

PCM Fund’s stock is valued at $11.42 at 02:24 EST, way below its 52-week high of $12.77 and way above its 52-week low of $9.67.

PCM Fund’s Moving Average

PCM Fund’s value is below its 50-day moving average of $11.68 and below its 200-day moving average of $11.67.

2. Invesco Credit Opportunities Fund (VTA)

157.89% Payout Ratio

Invesco Dynamic Credit Opportunities Fund is a close-ended fixed income mutual fund launched by Invesco Ltd.

Volume

Today’s last reported volume for Invesco Credit Opportunities Fund is 403702, 14.33% above its average volume of 353079.

As stated by Morningstar, Inc., the next dividend payment is on Sep 12, 2018, the estimated forward annual dividend rate is 0.9 and the estimated forward annual dividend yield is 7.66%.

Year-on-year quarterly revenue growth declined by 32.7%, now sitting on 57.37M for the twelve trailing months.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.68%.

Volatility

Invesco Credit Opportunities Fund’s last day, week, and month’s current volatility was 0.43%, 0.31%, and 0.20%, respectively.

Invesco Credit Opportunities Fund’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 0.61% (day), 0.49% (last week), and 0.41% (last month), respectively.

Invesco Credit Opportunities Fund’s Stock Yearly Top and Bottom Value

Invesco Credit Opportunities Fund’s stock is valued at $11.65 at 02:24 EST, below its 52-week high of $11.99 and way above its 52-week low of $9.10.

Invesco Credit Opportunities Fund’s Moving Average

Invesco Credit Opportunities Fund’s worth is under its 50-day moving average of $11.71 and higher than its 200-day moving average of $11.60.

3. Cullen/Frost Bankers (CFR)

44.43% Payout Ratio

Cullen/Frost Bankers, Inc. operates as the bank holding company for Frost Bank that offers commercial and consumer banking services in Texas.

Volume

Today’s last reported volume for Cullen/Frost Bankers is 225652, 19.9% below its average volume of 281733.

As stated by Morningstar, Inc., the next dividend payment is on Aug 29, 2021, the estimated forward annual dividend rate is 3 and the estimated forward annual dividend yield is 2.66%.

Cullen/Frost Bankers’s sales growth this year is expected to be negative 6.7% and a negative 1% for next year.

Year-on-year quarterly revenue growth grew by 19.5%, now sitting on 1.31B for the twelve trailing months.

Cullen/Frost Bankers’s sales growth is negative 0.1% for the current quarter and negative 1.1% for the next. The company’s growth estimates for the current quarter and the next is 2.7% and 0.7%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.96%.

Volatility

Cullen/Frost Bankers’s last day, week, and month’s current volatility was 0.56%, 1.05%, and 1.07%, respectively.

Cullen/Frost Bankers’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.84% (day), 2.13% (last week), and 1.93% (last month), respectively.

Cullen/Frost Bankers’s Stock Yearly Top and Bottom Value

Cullen/Frost Bankers’s stock is valued at $111.05 at 02:24 EST, way under its 52-week high of $125.00 and way higher than its 52-week low of $61.84.

Cullen/Frost Bankers’s Moving Average

Cullen/Frost Bankers’s value is below its 50-day moving average of $113.71 and under its 200-day moving average of $113.83.

4. Hercules Technology Growth Capital (HTGC)

43.69% Payout Ratio

Volume

Today’s last reported volume for Hercules Technology Growth Capital is 435267, 31.7% below its average volume of 637349.

As stated by Morningstar, Inc., the next dividend payment is on Aug 9, 2021, the estimated forward annual dividend rate is 1.28 and the estimated forward annual dividend yield is 7.74%.

Hercules Technology Growth Capital’s sales growth this year is anticipated to be negative 1.8% and 7.1% for next year.

Year-on-year quarterly revenue growth grew by 2.3%, now sitting on 283.99M for the twelve trailing months.

Hercules Technology Growth Capital’s sales growth is 1.5% for the current quarter and negative 3.9% for the next. The company’s growth estimates for the present quarter and the next is negative 2.9% and negative -8.1%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 27.07%.

Volatility

Hercules Technology Growth Capital’s last day, week, and month’s current volatility was 1.51%, 0.83%, and 0.75%, respectively.

Hercules Technology Growth Capital’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 0.84% (day), 1.23% (last week), and 1.28% (last month), respectively.

Hercules Technology Growth Capital’s Stock Yearly Top and Bottom Value

Hercules Technology Growth Capital’s stock is valued at $16.79 at 02:24 EST, under its 52-week high of $17.75 and way higher than its 52-week low of $10.81.

Hercules Technology Growth Capital’s Moving Average

Hercules Technology Growth Capital’s worth is under its 50-day moving average of $16.91 and below its 200-day moving average of $16.93.

5. CVS Health (CVS)

35.59% Payout Ratio

CVS Health Corporation provides health services and plans in the United States.

Volume

Today’s last reported volume for CVS Health is 3654240, 31.51% below its average volume of 5335600.

As maintained by Morningstar, Inc., the next dividend payment is on Jul 21, 2021, the estimated forward annual dividend rate is 2 and the estimated forward annual dividend yield is 2.38%.

CVS Health’s sales growth this year is anticipated to be 5.6% and 4.2% for next year.

Year-on-year quarterly revenue growth grew by 3.3%, now sitting on 270.11B for the twelve trailing months.

CVS Health’s sales growth is 5.5% for the current quarter and 3.3% for the next. The company’s growth estimates for the present quarter and the next is 6.6% and 21.5%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.85%.

Volatility

CVS Health’s last day, week, and month’s current volatility was 0.59%, 1.20%, and 1.05%, respectively.

CVS Health’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.34% (day), 2.08% (last week), and 1.76% (last month), respectively.

CVS Health’s Stock Yearly Top and Bottom Value

CVS Health’s stock is valued at $83.86 at 02:24 EST, below its 52-week high of $90.61 and way above its 52-week low of $55.36.

CVS Health’s Moving Average

CVS Health’s value is below its 50-day moving average of $84.48 and above its 200-day moving average of $81.55.

Previous days news about CVS Health (CVS)

  • According to Bloomberg Quint on Friday, 24 September, "Airlines are struggling to fill entry-level jobs, competing with companies like CVS Health Corp. that have increased pay and offered incentives to win over prospective hires. "
  • According to Bloomberg Quint on Friday, 24 September, "Walgreens Boots Alliance, Inc., Walmart Inc. and CVS Health Corp. said they began giving third shots across the U.S."
  • According to Bloomberg Quint on Friday, 24 September, "Walgreens Boots Alliance Inc. is boosting its wage floor in the U.S. to $15 per hour after rival CVS Health Corp. said it would do the same. "
  • According to Benzinga on Thursday, 23 September, "The company’s client portfolio includes very well-known brands such as CVS Health (NYSE: CVS), JPMorgan Chase (NYSE: JPM), and Accenture (NYSE: ACN), who believe investing in their workers is essential to the long-term financial success of their companies."
  • According to Bloomberg Quint on Friday, 24 September, "Separately, Walmart Inc. and CVS Health Corp. announced that their pharmacies have also begun offering booster shots for qualified individuals."

LEAVE A REPLY

Please enter your comment!
Please enter your name here